F&V Capital Management LLC Sells 5,110 Shares of CVS Health Co. (NYSE:CVS)

F&V Capital Management LLC lowered its position in CVS Health Co. (NYSE:CVS) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,514 shares of the pharmacy operator’s stock after selling 5,110 shares during the period. CVS Health accounts for 1.6% of F&V Capital Management LLC’s portfolio, making the stock its 26th largest holding. F&V Capital Management LLC’s holdings in CVS Health were worth $6,083,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Jennison Associates LLC bought a new position in CVS Health in the 4th quarter valued at $14,099,000. Copeland Capital Management LLC bought a new position in shares of CVS Health in the fourth quarter valued at about $104,000. Avantra Family Wealth Inc. acquired a new position in CVS Health during the 4th quarter worth about $506,000. Spire Wealth Management grew its holdings in CVS Health by 27.0% during the 4th quarter. Spire Wealth Management now owns 12,397 shares of the pharmacy operator’s stock worth $556,000 after acquiring an additional 2,634 shares during the last quarter. Finally, Deroy & Devereaux Private Investment Counsel Inc. acquired a new stake in CVS Health in the 4th quarter valued at about $17,709,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CVS has been the topic of several research analyst reports. Piper Sandler decreased their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Mizuho dropped their target price on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada cut their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Stock Down 0.9 %

Shares of CVS Health stock opened at $55.99 on Tuesday. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market capitalization of $70.46 billion, a P/E ratio of 14.21, a price-to-earnings-growth ratio of 0.62 and a beta of 0.61. The business has a 50-day moving average of $51.24 and a two-hundred day moving average of $56.13.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the company posted $2.21 EPS. As a group, equities analysts predict that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.75%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.